KRAS and neoplasm: However, apart from FN1 being identified to be associated with diagnosis age (P = 0.021) (Fig. 9), other clinical features, including sex, tumor stage, histologic type, metastatic status and KRAS mutation, were evaluated separately, and no significant associations with 11 miRNA targets were observed (Supplementary Figs. 2, 3 and 4).